<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://thebostonexaminer.com/article/915439389-the-new-everyday-opens-on-bleecker-street-nine-brands-showcase-the-products-rewriting-daily-life</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T21:51:48+00:00</news:publication_date>
        <news:title>The New Everyday Opens on Bleecker Street: Nine Brands Showcase the Products Rewriting Daily Life</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24869492-the-new-everyday-nyc-pop-up-sho-2000x1126.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915257890-golfcoursehome-com-adds-eight-lakewood-ranch-area-golf-communities-to-its-florida-featured-communities-line-up</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T14:00:00+00:00</news:publication_date>
        <news:title>GolfCourseHome.com Adds Eight Lakewood Ranch-Area Golf Communities to Its Florida Featured Communities Line-Up</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867888-gch-logo-565x535.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915181621-o-ryan-health-announces-hsa-and-fsa-eligibility-for-at-home-pediatric-wellness-kits</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T13:00:00+00:00</news:publication_date>
        <news:title>O’Ryan Health Announces HSA and FSA Eligibility for At-Home Pediatric Wellness Kits</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24868474-hsa-fsa-approved-1080x1080.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915183027-psmj-resources-highlights-exhibitors-and-sponsors-for-aec-innovate-26</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T13:00:00+00:00</news:publication_date>
        <news:title>PSMJ Resources Highlights Exhibitors and Sponsors for AEC INNOVATE ‘26</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915420577-creatio-introduces-unlimited-enterprise-for-the-ai-era</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:43:32+00:00</news:publication_date>
        <news:title>Creatio Introduces Unlimited Enterprise for the AI Era</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24868428-creatio-unlimited-enterprise-2400x1256.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/906777722-realm-music-group-launches-premium-sync-licensing-services-featuring-fully-owned-catalog-by-artist-producer-ricki-erik</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:30:00+00:00</news:publication_date>
        <news:title>Realm Music Group Launches Premium Sync Licensing Services Featuring Fully-Owned Catalog by Artist/Producer Ricki Erik</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835807-ricki-erik-singer-songwriter-1024x768.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915150499-laxcoach-ai-launches-ios-app-for-lacrosse-shot-analysis</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:12:15+00:00</news:publication_date>
        <news:title>LaxCoach AI Launches iOS App for Lacrosse Shot Analysis</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/914770628-chinese-academy-of-sciences-study-uncovers-hidden-drivers-of-haze-pollution</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T10:30:00+00:00</news:publication_date>
        <news:title>Chinese Academy of Sciences Study Uncovers Hidden Drivers of Haze Pollution</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24865626-esjca-21-3-453x438.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915534165-imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T20:30:00+00:00</news:publication_date>
        <news:title>ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915517036-aktis-oncology-to-present-at-the-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T20:05:00+00:00</news:publication_date>
        <news:title>Aktis Oncology to Present at the Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915517361-amsc-reports-fourth-quarter-and-fiscal-year-2025-financial-results-and-business-outlook</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T20:05:00+00:00</news:publication_date>
        <news:title>AMSC Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Outlook</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e211940b-e356-45ff-b867-4d8c2353e215/small/unknown-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915517369-relay-therapeutics-to-participate-in-two-upcoming-investor-conferences-in-june</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T20:05:00+00:00</news:publication_date>
        <news:title>Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915486341-icic-opens-applications-for-greater-boston-transformative-business-accelerator</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T17:09:39+00:00</news:publication_date>
        <news:title>ICIC Opens Applications for Greater Boston Transformative Business Accelerator</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ODcyNDc4YzctZDE0MS00MjdiLTg5NTctNGQ1MzhhYTQxMTliLTEyOTc0NjgtMjAyNi0wNS0yNy1lbg==/tiny/ICIC.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915299414-todd-patkin-releases-expanded-edition-of-finding-happiness-a-memoir-for-the-burnout-generation</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T04:58:36+00:00</news:publication_date>
        <news:title>Todd Patkin Releases Expanded Edition of &#39;Finding Happiness&#39; — A Memoir for the Burnout Generation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867477-finding-happiness-book-cover-1000x1430.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915460048-sgh-expands-building-enclosure-consulting-presence-in-atlanta</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T14:47:58+00:00</news:publication_date>
        <news:title>SGH Expands Building Enclosure Consulting Presence in Atlanta</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/61e42831-ed17-49c5-b81f-5010b36bc8da/medium/sgh-portrait-edward-bernard.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915459759-color-changing-epaper-concept-car-to-make-its-debut-at-computex-2026</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T14:29:39+00:00</news:publication_date>
        <news:title>Color-Changing ePaper Concept Car to Make Its Debut at COMPUTEX 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/40cd0745-9b2c-49b4-8d51-813b4fc78656/medium/color-changing-epaper-concept.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915446278-paragonix-announces-launch-of-concert-dcd-clinical-trial-in-collaboration-with-uw-medicine-to-maximize-heart-transplant-utilization</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T13:00:00+00:00</news:publication_date>
        <news:title>Paragonix Announces Launch of CONCERT-DCD Clinical Trial in Collaboration with UW Medicine to Maximize Heart Transplant Utilization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915446298-digital-twin-consortium-welcomes-xaba-as-a-member</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T13:00:00+00:00</news:publication_date>
        <news:title>Digital Twin Consortium Welcomes Xaba as a Member</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjU5ZTExYjgtNjc4Ny00M2U4LWFjNDgtMjAzN2ZjYTlhYjg3LTEyMjAzMjItMjAyNi0wNS0yNy1lbg==/tiny/Digital-Twin-Consortium.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433661-exascale-labs-to-present-at-guosheng-securities-sst-industry-forum-in-shanghai-on-may-29-2026</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:31:00+00:00</news:publication_date>
        <news:title>Exascale Labs to Present at Guosheng Securities SST Industry Forum in Shanghai on May 29, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/67242d8b-6603-429c-ab27-e5cd8a89de1c/small/exascale-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433401-lantheus-to-present-at-the-william-blair-46th-annual-growth-stock-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:30:00+00:00</news:publication_date>
        <news:title>Lantheus to Present at the William Blair 46th Annual Growth Stock Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7ff76065-4799-4307-9b3d-033643bacc35/small/lantheus-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433682-liberty-defense-deploys-hexwave-at-laguardia-terminal-b-expanding-footprint-in-high-traffic-u-s-airports-and-announces-shares-for-debt-settlement</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:30:00+00:00</news:publication_date>
        <news:title>Liberty Defense Deploys HEXWAVE at LaGuardia Terminal B, Expanding Footprint in High-Traffic U.S. Airports and announces Shares for Debt Settlement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e3680d7e-614f-4715-8d2b-337dbd073cbc/small/liberty-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433802-electra-ai-adds-strategic-advisory-board-appoints-carmine-villani-as-first-strategic-advisor</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:30:00+00:00</news:publication_date>
        <news:title>ELECTRA AI Adds Strategic Advisory Board; Appoints Carmine Villani as First Strategic Advisor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NmViNTY0YTMtN2IxZi00NmQzLTljZjgtYjEzYjI0YTQ1NDY3LTEzMjI5MjctMjAyNi0wNS0yNy1lbg==/tiny/ELECTRA-AI.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433538-ernexa-therapeutics-successfully-completes-key-manufacturing-and-ind-preparation-milestones-for-erna-101-toward-first-in-human-clinical-development</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:11:00+00:00</news:publication_date>
        <news:title>Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915243255-bert-hill-moving-storage-continues-to-set-the-standard-for-assisted-living-relocations-in-western-ma-and-northern-ct</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T00:00:00+00:00</news:publication_date>
        <news:title>Bert Hill Moving &amp; Storage Continues to Set the Standard for Assisted Living Relocations In Western MA and Northern CT</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867697-bert-hill-moving-storage-1200x934.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433006-sionna-therapeutics-to-participate-in-upcoming-june-2026-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:00:00+00:00</news:publication_date>
        <news:title>Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433016-collegium-to-participate-in-2026-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:00:00+00:00</news:publication_date>
        <news:title>Collegium to Participate in 2026 Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c9077b27-1a69-42a5-9f77-e39124f4d2a2/small/collegium-rgb-large-r-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433064-avalyn-to-participate-in-the-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:00:00+00:00</news:publication_date>
        <news:title>Avalyn to Participate in the Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433226-cogent-biosciences-announces-participation-in-the-2026-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:00:00+00:00</news:publication_date>
        <news:title>Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433324-rectify-pharmaceuticals-presents-new-translational-data-at-easl-2026-supporting-rty-406-its-clinical-candidate-for-the-treatment-of-primary</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:00:00+00:00</news:publication_date>
        <news:title>Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bdac6aa0-18b4-4330-98a1-e9673a671b69/small/rectify-logo-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433467-zapata-s-harvard-quantum-lab-co-founders-drs-cao-and-olson-return-as-cto-and-vp-of-strategy-and-operations</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:00:00+00:00</news:publication_date>
        <news:title>Zapata’s Harvard Quantum Lab Co-Founders Drs. Cao and Olson Return as CTO and VP of Strategy and Operations</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/56af279d-d179-411c-82ab-b1ba4f7f9b20/small/blank-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915433808-hemab-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T12:00:00+00:00</news:publication_date>
        <news:title>Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c5d70227-b7a8-4280-bd6b-389252a2e5b3/small/hemab-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915421262-methane-pyrolysis-market-to-reach-484-million-by-2030-driven-by-clean-hydrogen-demand</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:32:26+00:00</news:publication_date>
        <news:title>Methane Pyrolysis Market to Reach $484 Million by 2030, Driven by Clean Hydrogen Demand</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915420295-kymera-therapeutics-to-participate-in-fireside-chat-at-the-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:00:00+00:00</news:publication_date>
        <news:title>Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915420351-atea-pharmaceuticals-presents-new-drug-drug-interaction-results-supporting-potential-best-in-class-profile-of-the-regimen-of-bemnifosbuvir-and</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:00:00+00:00</news:publication_date>
        <news:title>Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915420909-korro-to-present-at-the-2026-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:00:00+00:00</news:publication_date>
        <news:title>Korro to Present at the 2026 Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915420916-x4-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:00:00+00:00</news:publication_date>
        <news:title>X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c8d99a6-5cb7-4826-ae93-6c84d7f84355/small/x4-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915420863-apogee-therapeutics-announces-1-3-billion-strategic-financing-collaboration-with-blackstone-life-sciences-to-advance-phase-3-development-and</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T10:31:00+00:00</news:publication_date>
        <news:title>Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915420869-apogee-therapeutics-announces-positive-16-week-part-b-induction-dose-optimization-results-from-phase-2-apex-trial-of-zumilokibart-in</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T10:30:00+00:00</news:publication_date>
        <news:title>Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915421147-nano-dimension-announces-sale-of-markforged-inc-to-stratasys</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T10:30:00+00:00</news:publication_date>
        <news:title>Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dd1b96fc-0b19-4125-bdcb-867c52c8f415/small/logo-nd-nw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915384726-gordon-brothers-offering-for-sale-by-private-treaty-a-fully-electric-landing-utility-vessel</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T08:00:00+00:00</news:publication_date>
        <news:title>Gordon Brothers Offering for Sale by Private Treaty a Fully Electric Landing Utility Vessel</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MzBiODc4ZWEtZDZjNi00YzEwLWJjNjktMGMzZWUyZTNhNmYzLTExMTAxODYtMjAyNi0wNS0yNy1lbg==/tiny/Gordon-Brothers.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915212085-choroideremia-research-foundation-announces-june-30-research-grant-application-deadline</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T18:14:44+00:00</news:publication_date>
        <news:title>Choroideremia Research Foundation Announces June 30 Research Grant Application Deadline</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867463-june-30-grant-1280x720.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/913637191-innovative-life-changing-tms-therapy-at-northeast-health-services-boston-government-center-clinic</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T16:15:00+00:00</news:publication_date>
        <news:title>Innovative, Life Changing TMS Therapy at Northeast Health Services&#39; Boston Government Center Clinic</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861076-tms1-1024x769.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915186748-pos-supply-solutions-expands-product-line-rebrands-pos-sticky-labels-as-quickstick-receipt-labels-for-restaurants-qsrs</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T15:02:45+00:00</news:publication_date>
        <news:title>POS Supply Solutions Expands Product Line &amp; Rebrands POS Sticky Labels as QuickStick Receipt Labels for Restaurants/QSRs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867248-quickstick-receipt-labels-on-fo-3164x1779.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/914233987-hanover-high-school-senior-ava-khouri-publishes-inspiring-children-s-book-the-apple-of-my-pie</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T14:30:00+00:00</news:publication_date>
        <news:title>Hanover High School Senior Ava Khouri Publishes Inspiring Children’s Book: The Apple of My Pie</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851063-aomp-cover-2338x2338.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915181417-the-cottagers-incorporated-of-martha-s-vineyard-celebrate-70-years-of-service-and-giving</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T14:25:29+00:00</news:publication_date>
        <news:title>The Cottagers Incorporated of Martha&#39;s Vineyard Celebrate 70 Years of Service and Giving</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867143-70th-anniversary-group-photo-985x337.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/911838942-this-men-s-mental-health-month-boston-gynecomastia-specialists-highlights-gynecomastia-s-impact-on-men-s-mental-health</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T14:00:00+00:00</news:publication_date>
        <news:title>This Men&#39;s Mental Health Month, Boston Gynecomastia Specialists highlights Gynecomastia’s impact on men’s mental health</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24852300-male-breast-reduction-results-a-961x1274.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/914901616-new-england-patriots-rb-treveyon-henderson-stars-in-announcement-video-as-gripped-book-series-heads-to-television</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T14:00:00+00:00</news:publication_date>
        <news:title>New England Patriots RB TreVeyon Henderson Stars in Announcement Video as Gripped Book Series Heads to Television </news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24866022-stacy-trey-filming-1182x886.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915168763-ultrasight-study-shows-novices-achieve-diagnostic-quality-cardiac-ultrasound-after-one-day-of-ai-guided-training</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T13:12:40+00:00</news:publication_date>
        <news:title>UltraSight™ Study Shows Novices Achieve Diagnostic-Quality Cardiac Ultrasound After One Day of AI-Guided Training</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22432389-ultrasight-logo-3442x1396.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/913662712-stanford-study-finds-contingency-management-highly-cost-effective-for-methamphetamine-use-disorder</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T13:00:00+00:00</news:publication_date>
        <news:title>Stanford Study Finds Contingency Management Highly Cost-Effective for Methamphetamine Use Disorder</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24539771-cmi-logo-1650x732.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915286561-breaking-verra-mobility-shares-plummet-following-termination-of-avis-agreement-investors-should-contact-block-leviton-to-possibly-recover-losses</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T22:52:22+00:00</news:publication_date>
        <news:title>BREAKING: Verra Mobility Shares Plummet Following Termination of Avis Agreement; Investors Should Contact Block &amp; Leviton to Possibly Recover Losses</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915261461-caswell-plumbing-and-heating-recognized-as-top-rated-plumber-in-framingham-ma-by-best-of-2026-businessrate</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:32:00+00:00</news:publication_date>
        <news:title>Caswell Plumbing and Heating Recognized as Top Rated Plumber in Framingham, MA by Best of 2026 BusinessRate</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3321366/Caswell-Plumbing-and-Heating-in-Framinham%2C-MA---master-plumber-tim-caswell.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915249810-destination-xl-group-inc-recommends-dxl-shareholders-reject-zodiac-partners-ii-s-tender-offer-and-not-tender-their-shares</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:25:00+00:00</news:publication_date>
        <news:title>Destination XL Group, Inc. Recommends DXL Shareholders Reject Zodiac Partners II’s Tender Offer And NOT Tender Their Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6ecdc08b-a991-4864-bec7-55382a7936d8/small/dxl-b-t-2020-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915249337-spyre-therapeutics-to-participate-in-upcoming-june-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:10:00+00:00</news:publication_date>
        <news:title>Spyre Therapeutics to Participate in Upcoming June Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915249352-jade-biosciences-announces-first-participant-dosed-in-first-in-human-phase-1-clinical-trial-of-jade201-a-novel-half-life-extended-afucosylated</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:05:00+00:00</news:publication_date>
        <news:title>Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915249364-cargurus-to-present-at-the-bofa-securities-2026-global-technology-conference</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:05:00+00:00</news:publication_date>
        <news:title>CarGurus to Present at the BofA Securities 2026 Global Technology Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e9ed825-143d-405a-9794-acd1a1ded2cc/small/cg-logo-2025-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915249585-kailera-reports-first-quarter-2026-financial-results-and-provides-clinical-data-updates</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:02:00+00:00</news:publication_date>
        <news:title>Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915249554-apogee-therapeutics-to-host-conference-call-to-report-part-b-16-week-data-from-the-phase-2-apex-trial-of-zumilokibart-in-patients-with</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:01:00+00:00</news:publication_date>
        <news:title>Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915249667-molecular-partners-to-present-at-td-cowen-s-7th-annual-oncology-innovation-summit</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:00:00+00:00</news:publication_date>
        <news:title>Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915237931-gordon-brothers-acquires-radley-brand</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T18:48:25+00:00</news:publication_date>
        <news:title>Gordon Brothers Acquires Radley Brand</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ODllMDQxZWUtMzIyZS00NjI0LThkZjMtYTY4M2Q0NTU4M2JiLTExMTAxODYtMjAyNi0wNS0yNi1lbg==/tiny/Gordon-Brothers.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915192074-astra-tower-achieves-leed-gold-certification-advancing-sustainable-living-in-salt-lake-city</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T14:34:07+00:00</news:publication_date>
        <news:title>Astra Tower Achieves LEED Gold Certification, Advancing Sustainable Living in Salt Lake City</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ODEyMDUwNWMtOGRmMS00NGE5LWIzYjktZTRjNzUyM2I2MTJmLTUwMDE2MjkwMC0yMDI2LTA1LTI2LWVu/tiny/Kensington-Investment-Company.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915183417-the-value-of-extending-the-diablo-canyon-nuclear-plant-s-operating-life</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T14:05:00+00:00</news:publication_date>
        <news:title>The Value of Extending the Diablo Canyon Nuclear Plant’s Operating Life</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Y2VlNzM4ZTktODIzYS00YTAxLTk1ZDktMGJkODJmNmJjZWRmLTEyNzMzMTEtMjAyNi0wNS0yNi1lbg==/tiny/MIT-Sloan-School-of-Management.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915175871-mit-sloan-executive-education-expands-portfolio-of-ai-courses-and-certifications</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T13:15:00+00:00</news:publication_date>
        <news:title>MIT Sloan Executive Education Expands Portfolio of AI Courses and Certifications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YTY0YzExZjMtYjliYS00OTRkLWJkY2QtODkyYmZhZDZhMTk0LTEzMTMzNzgtMjAyNi0wNS0yNi1lbg==/tiny/MIT-Sloan-Executive-Education.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915176613-editas-medicine-announces-pricing-of-up-to-319-4-million-public-offering</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T13:05:00+00:00</news:publication_date>
        <news:title>Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915176270-nift-adds-former-disney-and-espn-executive-as-commerce-media-platform-accelerates-growth</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T13:00:00+00:00</news:publication_date>
        <news:title>Nift Adds Former Disney and ESPN Executive as Commerce Media Platform Accelerates Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/52123161-2250-400d-8f24-2cc78e6a5dc6/medium/nift-appoints-marc-mallett-as-senior-partner-sales-director.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915168432-nodthera-announces-the-publication-and-presentation-of-cardiometabolic-clinical-data-supporting-the-potential-of-ruvonoflast-to-treat-inflammation-at</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T12:45:00+00:00</news:publication_date>
        <news:title>NodThera Announces the Publication and Presentation of Cardiometabolic Clinical Data Supporting the Potential of Ruvonoflast to Treat Inflammation at the Source</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/47e7b50f-0ca3-4bf3-8a6b-753432486e1c/small/nodthera-logo-full-color-rgb-high-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915168800-microbot-medical-receives-its-first-international-regulatory-approval-for-the-commercialization-of-the-liberty-endovascular-robotic-system</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T12:30:00+00:00</news:publication_date>
        <news:title>Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915160263-rhythm-pharmaceuticals-announces-participation-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T12:00:00+00:00</news:publication_date>
        <news:title>Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915160471-after-7-million-investigations-in-production-7ai-widens-the-gap-in-agentic-security-with-plaid-elite-and-100-new-ai-jobs-in-boston</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T12:00:00+00:00</news:publication_date>
        <news:title>After 7 Million Investigations in Production, 7AI Widens the Gap in Agentic Security with PLAID ELITE and 100 New AI Jobs in Boston</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/49a75202-5661-422f-b6dd-4be441d0c02c/small/7ai-logo-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915160612-nano-dimension-issues-letter-to-shareholders</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T12:00:00+00:00</news:publication_date>
        <news:title>Nano Dimension Issues Letter to Shareholders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dd1b96fc-0b19-4125-bdcb-867c52c8f415/small/logo-nd-nw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915160621-vicor-corporation-revises-q2-2026-revenue-guidance</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T12:00:00+00:00</news:publication_date>
        <news:title>Vicor Corporation Revises Q2 2026 Revenue Guidance</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/55117480-366f-4254-a0c3-1c89d863eb54/small/1200x628-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915160575-dyne-therapeutics-announces-submission-of-biologics-license-application-bla-to-u-s-fda-for-z-rostudirsen-in-exon-51-duchenne-muscular-dystrophy</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T11:30:00+00:00</news:publication_date>
        <news:title>Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915153348-jade-biosciences-announces-first-participant-dosed-in-phase-2-juniper-clinical-trial-of-jade101-in-iga-nephropathy</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T11:00:00+00:00</news:publication_date>
        <news:title>Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915153437-corbus-pharmaceuticals-reports-updated-crb-701-phase-1-2-clinical-data-demonstrating-robust-activity-in-2l-oropharyngeal-and-cervical-cancers</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T11:00:00+00:00</news:publication_date>
        <news:title>Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915153443-climb-bio-to-present-on-clym116-and-budoprutug-programs-at-european-renal-association-era-congress-2026</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T11:00:00+00:00</news:publication_date>
        <news:title>Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915153470-cullinan-therapeutics-to-host-immunology-day-to-showcase-promising-initial-clinical-data-in-autoimmune-diseases-for-cln-978-a-cd19-t-cell-engager</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T11:00:00+00:00</news:publication_date>
        <news:title>Cullinan Therapeutics to Host Immunology Day to Showcase Promising Initial Clinical Data in Autoimmune Diseases for CLN-978, a CD19 T Cell Engager, and Velinotamig, a BCMA T Cell Engager</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3f4113d3-b651-4c00-bd96-c1ff9384b1de/small/cullinan-logo-rgb-clr-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915145961-editas-medicine-announces-proposed-public-offering</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T10:15:03+00:00</news:publication_date>
        <news:title>Editas Medicine Announces Proposed Public Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915139253-editas-medicine-presents-edit-401-preclinical-data-demonstrating-robust-reductions-in-ldl-c-lp-a-and-apob-in-non-human-primates-at-the-94th</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T10:01:00+00:00</news:publication_date>
        <news:title>Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915139265-tycho-ai-validates-halley-vtol-uas-with-successful-c-uas-and-one-way-attack-demonstrations-at-t-rex-26-2</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T10:00:00+00:00</news:publication_date>
        <news:title>Tycho.AI Validates Halley VTOL UAS with Successful C-UAS and One-Way Attack Demonstrations at T-REX 26-2</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/01f322ae-b547-4672-a5f6-624854b088da/medium/halley-soars-at-t-rex-26-2.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://thebostonexaminer.com/article/915139244-wind-turbine-blade-recycling-market-to-reach-158-9-billion-by-2030-driven-by-massive-wave-of-turbine-decommissioning</loc>
      <news:news>
        <news:publication>
          <news:name>The Boston Examiner</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T09:32:00+00:00</news:publication_date>
        <news:title>Wind Turbine Blade Recycling Market to Reach $158.9 Billion by 2030, Driven by Massive Wave of Turbine Decommissioning</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
</urlset>
